Great Lakes Advisors, LLC Editas Medicine, Inc. Transaction History

Great Lakes Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$39.71 - $90.58 $15.1 Million - $34.4 Million	-380,011 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$27.07 - $84.35 $10.3 Million - $32.1 Million	380,011 New	380,011 $26.6 Million
Q2 2019 Aug 05, 2019	SELL	$20.48 - $27.76 $5.66 Million - $7.67 Million	-276,195 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$19.43 - $26.41 $5.37 Million - $7.29 Million	276,195 New	276,195 $6.75 Million
Q4 2017 Feb 08, 2018	SELL	$21.89 - $31.34 $235,623 - $337,343	-10,764 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$15.81 - $24.01 $170,178 - $258,443	10,764	10,764 $258,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.